Nanjing Chinese Medicine - the future of pharmaceutical business a dark horse.docVIP

 PAGE \* MERGEFORMAT 12 Nanjing Chinese Medicine - the future of pharmaceutical business a dark horse China’s future pharmaceutical business who dominate the field, I think that the future may be the high-end medical market in Nanjing Medicine, Nanjing Medical will become a dark horse. Let’s take a look at: Nanjing Medical main income of the first three quarters of 2007, net profit reached 6.719 billion yuan, respectively, 49.6361 million yuan, respectively, an increase of 32.29 percent, 149.61 percent, earnings per share were 0.14 yuan. These results is behind the strategic transformation of Nanjing will be medical, pharmacy purchases through outsourcing, IT information, logistics and distribution, to itself as a professional ‘pharmacy management integration service provider’, which is positioned will be the development of China’s pharmaceutical business One of the trends. I said that medicine will soon become a dark horse in Nanjing, mainly its surrounding its ‘Pharmacy Integration Service Providers’ position to judge after a series of moves, the real beginning of Medicine, Nanjing Medical management of profitable business models change, Nanjing Medical mainly the following five strokes, Zhao Zhao to the point. 1, the capital of yuan to expand the development of multi-drive Nanjing, Nanjing Pharmaceutical Co., Ltd. was founded in Medicine in December 1951, is the planned economic system in Nanjing two pharmaceutical procurement and supply station in 1998 to expand the company take the extension of the road, the acquisition of Jiangsu, Anhui, Fujian and other places pharmaceutical distribution business and pharmaceutical retail enterprises, the scale quickly to a higher level, from 1997 to 580 million rose to 6.2 billion in 2005 to become East region’s key pharmaceutical procurement and supply centers, distributors, ranked fourth in the scale. Is a typical and pharmaceutical distribution industry, expansion of corporate structure in 2005, 98% of revenue